Wolverine Trading, LLC Evolus, Inc. Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.99 - $14.91 $18,241 - $27,225	-1,826 Reduced 13.33%	11,871 $166,000
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $104,097 - $144,229	13,697 New	13,697 $144,000
Q2 2020 Aug 13, 2020	SELL	$3.53 - $6.17 $3,702 - $6,472	-1,049 Reduced 4.04%	24,911 $135,000
Q1 2020 May 11, 2020	BUY	$3.53 - $12.21 $44,770 - $154,859	12,683 Added 95.53%	25,960 $105,000
Q4 2019 Feb 12, 2020	BUY	$11.58 - $17.37 $153,747 - $230,621	13,277 New	13,277 $154,000
Q1 2019 May 15, 2019	SELL	$12.43 - $28.91 $148,898 - $346,312	-11,979 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$10.57 - $19.29 $126,618 - $231,074	11,979 New	11,979 $143,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.